GlassScriptPhysician profile
Nader Mahmood
NPI 1396906913
$41,744.24
in general payments reported to CMS, 2019-2025
41 companies · $27K in 2025
The $27K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $8,152 · 2021: $1,721 · 2022: $942 · 2023: $1,823 · 2024: $1,687 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Honoraria: $10K · Food and Beverage: $6,948 · Travel and Lodging: $975 · Education: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,525.00 |
| Honoraria | $10,000.00 |
| Food and Beverage | $6,948.41 |
| Travel and Lodging | $974.70 |
| Education | $684.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14,827.00 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Verona Pharma, INC. | $12,003.09 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $10,947.09 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $565.16 | 2024-2025 | |
| Amgen INC. | $320.24 | 2021-2025 | Tezspire |
| Pulmonx Corporation | $289.27 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Philips North America LLC | $256.81 | 2019-2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $254.14 | 2022-2024 | Yupelri, Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.39 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Insmed, INC. | $234.24 | 2021-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $188.50 | 2019-2025 | Smartvest |
| Mallinckrodt Hospital Products INC. | $183.85 | 2020-2025 | Acthar |
| Sanofi-Aventis U.S. LLC | $138.79 | 2024-2025 | |
| Intuitive Surgical, INC. | $128.75 | 2025 | |
| Novartis Pharmaceuticals Corporation | $124.98 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $119.65 | 2023 | Wegovy |
| Ambu INC. | $117.87 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $117.04 | 2021-2025 | Dupixent |
| Viatris Specialty LLC | $99.32 | 2025 | Yupelri |
| Grifols USA, LLC | $54.19 | 2025 | Prolastin-C Liquid |
| Baxter Healthcare | $54.14 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $50.67 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $44.80 | 2024 | Purified Cortrophin Gel |
| Sunovion Pharmaceuticals INC. | $43.91 | 2020-2022 | |
| United Therapeutics Corporation | $34.25 | 2024-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $32.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.65 | 2020-2025 | Keytruda |
| Gilead Sciences, INC. | $27.44 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.54 | 2022 | |
| Inogen, INC. | $21.77 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $21.62 | 2022 | |
| Abiomed | $19.68 | 2025 | |
| Inari Medical, INC. | $17.54 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| 3b Medical, INC. | $15.99 | 2025 | Luna |
| Paratek Pharmaceuticals, INC. | $15.12 | 2023 | Nuzyra |
| Circassia INC. | $14.67 | 2020 | |
| Resmed Corp | $14.20 | 2024 | |
| Jazz Pharmaceuticals INC. | $14.12 | 2022 | |
| Inspire Medical Systems, INC. | $13.96 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $13.64 | 2025 | Opsumit |
| Mallinckrodt Enterprises LLC | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.